AstraZeneca's antibody cocktail fails to prevent Covid-19 in latest trial

The trial of 1,121 adult volunteers looked at whether the long-acting antibody combination could protect people who had recently been in contact with the SARS-CoV-2 virus in places like care homes.

from Latest News https://ift.tt/3wqLYvv
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share